tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market
KAPA
Kairos Pharma, Ltd.
RESEARCH TOOLSreports

Kairos Pharma, Ltd. (KAPA) Financial Statements

137 Followers

Kairos Pharma, Ltd. Financial Overview

Kairos Pharma, Ltd.'s market cap is currently $11.99M. The company's EPS TTM is $-0.197; its P/E ratio is -2.40; Kairos Pharma, Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -160.00K$ -160.00K$ -160.00K$ -98.00K
Operating Income$ -5.57M$ -2.34M$ -1.71M$ -571.00K$ -1.94M
EBITDA$ -5.29M$ -1.58M$ -1.55M$ -411.00K$ -1.84M
Net Income$ -5.45M$ -2.60M$ -1.81M$ -1.05M$ -2.15M
Balance Sheet
Cash & Short-Term Investments$ 4.49M$ 1.27M$ 93.00K$ 437.00K$ 73.00K
Total Assets$ 6.54M$ 6.22M$ 965.00K$ 1.04M$ 775.00K
Total Debt$ 0.00$ 0.00$ 638.00K$ 586.00K$ 380.00K
Net Debt$ -4.49M$ -1.27M$ 545.00K$ 149.00K$ 307.00K
Total Liabilities$ 199.00K$ 1.44M$ 3.04M$ 2.21M$ 1.94M
Stockholders' Equity$ 6.34M$ 4.78M$ -2.08M$ -1.18M$ -1.17M
Cash Flow
Free Cash Flow$ -3.44M$ -3.96M$ 81.00K$ -353.00K$ -412.00K
Operating Cash Flow$ -3.44M$ -3.96M$ 81.00K$ -353.00K$ -412.00K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ -109.00K
Financing Cash Flow$ 6.66M$ 5.13M$ -425.00K$ 717.00K$ 580.00K
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

Income Statement >

Kairos Pharma, Ltd. Debt to Assets

Balance Sheet >

Kairos Pharma, Ltd. Cash Flow

Cash Flow >

Kairos Pharma, Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >